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Introduction
The occurrence of metastases within inguinal lymphnodes
in patients with malignant melanoma of the lower
extremity is an important prognostic factor for the course
of the disease. The extent of surgical excision of the
lymphatic basin in this area (superficial versus superficial
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I n t r o d u c t i o n. The aim of this study was to identify the prognostic factors affecting the outcome of melanoma patients after
inguinal lymphadenectomy.
M a t e r i a l  a n d  m e t h o d s. We analysed 96 patients with melanoma of the lower extremity and its nodal metastases
treated between the years 1988 and 2000.
Re s u l t s. Patient staging: 2 pts. – IIIA; 19 pts. – IIIB; 75 pts. – IIIC. Ulceration of primary lesion – 47 pts (49%). Estimated
overall survival rates (OS): 50.7% at 2 yrs and 16.8% at 5 yrs. In case of pts with nodal metastases operated less than
12 months from initial treatment the 2 and 5-year survival rates were 43.5% and 9.7%, respectively, and in patients with nodal
involvement detected over12 months after initial surgery – 66.1% and 32.4%, respectively (p=0.002). Multivariate Cox’s
analysis of independent factors pointed at a rapid nodal metastases (p=0.009), involvement of deep nodes (p=0.015) and
ulceration of primary site (p=0.049) as unfavourable parameters influencing prognosis.
C o n c l u s i o n s. Although in stage III melanoma of the lower extremity prognosis is poor, ilioinguinal lymphadenectomy may
be beneficial. Unfavourable factors affecting survival include ulceration of primary site, deep node involvement and inguinal
metastases discernible less than 12 months after primary treatment.
Rokowanie u chorych na czerniaka z przerzutami do w´z∏ów ch∏onnych pachwinowych (III)
poddanych wyci´ciu w´z∏ów ch∏onnych
W p r o w a d z e n i e. Celem pracy jest ocena czynników prognostycznych u chorych na czerniaka skóry koƒczyn dolnych, po
wyci´ciu pachwinowego uk∏adu ch∏onnego.
M a t e r i a ∏  i m e t o d y k a. Przeanalizowano dane dotyczàce 96 chorych na czerniaka skóry koƒczyn dolnych z przerzutami
do regionalnych w´z∏ów ch∏onnych, leczonych w okresie od 1988 r. do 2000 r.
W y n i k i. Stwierdzono w zaawansowaniu IIIA – 2 chorych, IIIB – 19 chorych i IIIC – 75 chorych. U 47 chorych (49%)
stwierdzono owrzodzenie zmiany pierwotnej w obr´bie koƒczyny. Ca∏kowity odsetek prze˝yç dwuletnich wyniós∏ 50,7%,
prze˝yç pi´cioletnich 16,8%. WÊród chorych operowanych z powodu przerzutów do w´z∏ów ch∏onnych w okresie poni˝ej
12 miesi´cy od wyci´cia zmiany pierwotnej prze˝ycia dwuletnie wynios∏y 43,5%, a prze˝ycia pi´cioletnie 9,7%. W grupie
operowanych w czasie powy˝ej 12 miesi´cy od wyci´cia zmiany pierwotnej prze˝ycia dwuletnie wynios∏y 66,1%, natomiast
pi´cioletnie 32,4% (p=0,002). W wieloczynnikowej analizie Coxa niezale˝nymi niekorzystnymi czynnikami rokowniczymi by∏y:
krótki czas do stwierdzenia przerzutów w w´z∏ach ch∏onnych (p=0,009), zaj´cie w´z∏ów ch∏onnych biodrowych (p=0,015)
i owrzodzenie zmiany pierwotnej (p=0,049).
W n i o s k i. Rokowanie dla chorych na czerniaka skóry koƒczyn dolnych z przerzutami do w´z∏ów ch∏onnych jest powa˝ne,
jednak wyci´cie w´z∏ów ch∏onnych pachwinowych i biodrowych mo˝e znacznie poprawiaç rokowanie. Owrzodzenie zmiany
pierwotnej, zaj´cie przez przerzuty w´z∏ów ch∏onnych biodrowych oraz stwierdzenie przerzutów w w´z∏ach ch∏onnych wczeÊniej
ni˝ 12 miesi´cy od wyci´cia zmiany pierwotnej by∏y niekorzystnymi czynnikami prognostycznymi.
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and deep) is not well established. Elective lympha-
denectomy is no longer performed in patients with
melanoma of the lower limb. Most surgeons advocate en
bloc excision of both the superficial and deep inguinal
lymphnodes after confirming the presence of nodal
metastases. It must be kept in mind that deep inguinal
lymphadenctomy is associated with significant rise in
morbidity and therefore some centres limit surgery to
superficial inguinal lymphadenectomy. At the same time
attempts are made to define factors influencing the
appearance of deep inguinal metastases.
The aim of the current study was to assess the
prognostic factors affecting patients with melanoma of
the lower extremity and metastases to the superficial
and/or deep inguinal lymphnodes (stage III, AJCC/UICC
2002).
Material and methods
We analysed the cases of 112 patients with primary malignant
melanoma of the lower limb and metastases to superficial and/or
deep inguinal lymphnodes verified by aspiration cytology
operated between 1985 and 2000 in the Department of Surgical
Oncology of the Maria Sk∏odowska-Curie Memorial Cancer
Centre and Institute of Oncology in Kraków, Poland. Sixteen
patients were excluded from analysis due to non-cancer related
death, insufficient data on primary melanoma site or loss from
follow-up, i.e. the final retrospective analysis was performed on
96 patients.
Statistical analysis was performed with the aid of the
Statistica PL 5,1G (Statsoft Polska, Kraków, Poland).
Results
In 78% of patients the primary site of malignant
melanoma was within the foot or the lower leg. The
primary lesion was excised in the Department of Surgical
Oncology in 54% of patients. The excisions were
performed with clear surgical margins of at least 15 mm.
Table I presents the data concerning the primary found in
our patients.
In 21 patients (22%) metastases to the inguinal
lymphnodes were diagnosed synchronously with the
primary site. In this group the excision of primary lesion
and inguinal lymphadenectomy was performed synchro-
nously. In 50 patients (52%) inguinal lymphadenectomy
was performed within 12 months after the excision of
primary site. In the remaining 25 patients (26%) selective
lymphadenectomy was performed more than 12 months
after the excision of the primary site.
Mean age at the lymphadenectomy procedure was
53.3 years (22-85). Table II presents basic demographic
data of the analysed group.
The mean number of the excised superficial inguinal
lymphnodes was 7 (2-20). The mean number of metastatic
superficial inguinal lymphnodes was 3 (0-7). The mean
number of the excised deep inguinal lymphnodes was 4
(1-12). The mean number of metastatic deep inguinal
lymphnodes was 2 (0-7).
Metastatic superficial inguinal lymphnodes were
present in 89 patients (93%). Deep inguinal lymphnodes
contained metastases in 46 patients (49%). Histological
examination did not reveal involvement of superficial
nodes in 7 of these patients.
The Kaplan-Meier estimation of survival was 50.7%
at 2 years and 16.8% at 5 years. In the subgroup of
patients undergoing inguinal lymphadenectomy within
first 12 months after primary site excision estimation of
survival was 43.5% at 2 years and 9.7% at 5 years. In the
group undergoing inguinal lymphadenectomy 12 months
after the primary site excision survival was estimated at
66.1% ate 2 years and 32.4% at 5 years (Figure 1).
Multivariate Cox’s analysis has suggested that a short
time lapse between the primary site excision and
lymphadenectomy (p=0.009), the involvement of deep
inguinal lymphnodes (p=0.015) and ulceration of the
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Table III. Cox’s multivariate analysis of independent factors influencing survival
Factor Relative risk P-value
time between primary excision and lymphadenectomy, years 2.53 0.0009
deep nodes involved 2.79 0.015
ulceration of primary site 1.69 0.049
Table I. Characteristics of the primary tumour
Primary site of melanoma (%)
Foot 37 (38)
lower leg 38 (40)
thight 21 (22)
diameter, mm, mean (range) 25 (5-98)
clear margins, mm, mean (range) 15 (0-40)
ulceration (%) 47 (49)
Breslow scale, mm, mean (range) 6.5 (1-30)
Clark stage (%)
I 1 (1)
II 4 (4)
III 20 (21)
IV 34 (36)
V 21 (22)
n/a 16 (17)
n/a – data non-available
Table II. Basic characteristics of the analysed group (n = 96)
Age, mean (range) 53 (22-85)
women (%) 71 (74)
stage TNM-UICC 2002
IIIA 2 (2%)
IIIB 19 (20%)
IIIC 75 (78%)
primary site (p=0.049) are unfavourable factors for
survival (Table III).
Discussion
Superficial and deep inguinal lymphnodes are considered
to be the regional lymphatic basin for malignant mela-
noma of the lower extremity. Metastases found in this
area are determinants of stage III melanoma according to
the AJCC/UICC staging system. The treatment of choice
for these patients is primary site excision with wide
surgical margins and en bloc excision of deep and
superficial inguinal lymphnodes. Despite such aggressive
surgical treatment the prognosis for this subset of
melanoma patients is poor. According to different
authors, the 5 years survival rates vary between 20% and
40% [1, 2]. The most important factors influencing
survival are: the number of involved inguinal lymphnodes,
extracapsular infiltration and diameter of the biggest
metastatic inguinal lymphnode.
In the presented group, one of the factors influen-
cing survival was the length of the disease free interval
between excision of the primary lesion and inguinal
lymphadenectomy. The prognosis was worse for patients
with metastases found within inguinal lymphnode basin
no later than 12 months after excision of the primary
lesion. This observation is in concordance with data
presented by Hughes [3]. Hughes noticed that short
disease free interval negatively influenced risk for
dissemination, but did not reach statistical significance
in terms of overall survival.
The observed influence of the ulceration of the
primary lesion on the long-term survival of patients with
lymphnode metastases is an interesting finding. Mann
has observed a similar phenomenon [4]. The deter-
mination of the clinical course of the disease in patients
with involvement of inguinal lymphnodes acc. to the
primary site characteristics has already been mentioned in
several studies. Buzaid [5], Strobbe [6] and White [7]
report that the thickness of infiltration according to
Breslow influences survival. In a large meta-analysis of
almost 16000 melanoma patients Balch found tumour
thickness and ulceration to be among the most important
prognostic factors [8]. In our study it was the ulceration of
the primary site on the lower limb that negatively
correlated with survival. On the other hand, ulceration of
the primary site was not found to be statistically significant
in the studies by Strobbe [6] and Kretschmer [9].
There is an ongoing debate concerning the extent
of dissection in patients with melanoma involvement of
the inguinal lymphnodes. This aggressive surgical
approach was also a standard treatment in our depart-
ment. The opponents of this approach stress the
significant increase in morbidity after superficial and deep
inguinal lymphadenectomy when compared to superficial
lymphadenectomy only. The main complications after
deep lymphadenectomy include healing impairment and
increased lymphoedema formation in the lower extremity
[10]. In order to avoid these complications some authors
are trying to identify the factors allowing to identify the
subset of patients with a high risk of developing deep
inguinal lymphnode involvement. The status of the
superficial inguinal lymphnodes may suggest the status
of deep inguinal nodes. Among these predictive factors
Mann [4] points out: >3 involved nodes and diameter of
the biggest involved node >3 cm. Strobbe, in a recent
work, [11] examined the status of the Cloquet node as
a predictor of deep nodal status, but it was shown not to
be an efficient predicting tool. In conclusion Strobbe has
suggested performing deep lymphadenectomy in every
patient with positive inguinal nodes [11].
On the other hand a study presented by Hughes [3]
suggests, that deep inguinal lymphnodes dissection can be
performed with a relatively low complication rate. In this
study there was no statistical difference between the
complication rate after superficial lymphadenectomy as
compared with deep and superficial lymphadenectomy
[3]. Also a recent study by Lawton shows that by using
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Figure 1. Kaplan-Meier estimation of survival of patients undergoing lymphadenectomy within 12 months
after primary site excision and more than 2 months after primary surgery for melanoma
a technique of preserving the muscle fascia the rate of
lymphoedemas after deep node dissection can be
significantly limited without increasing the recurrence
risk [12]. If these results are confirmed it would suggest
superficial and deep lymphadenectomy to be of the
greatest value in patients with superficial lymph node
involvement.
In our study group the involvement of deep inguinal
lymphnodes was associated with poorer prognosis. It is of
particular interest that Mann [4] and Hughes [3] did not
find the involvement of deep inguinal lymphnodes to be
an important factor influencing survival. Basing on this
data, both they and Balch [13] advocate an aggressive
surgical approach in patients with clinical or radiological
suspicion of the deep inguinal lymphnode involvement.
This aggressive approach allows to obtain a 5-year survival
at 25-35%. The extent of surgery in patients with no signs
of deep inguinal lymphnode involvement still remains
arbitrary. This is caused by the lack of an efficient tool to
identify patients with the highest potential benefit from
superficial and deep lymphnodes excision [4]. Assuming
this to be true, the authors of the present report support
the aggressive surgical approach in patients without deep
lymphnode involvement.
The other issue concerning the attempts at omitting
deep lymphnode dissection is the problem of “skip
metastases”. In our material we had found 7 patients with
deep inguinal lymphnode involvement without metasteses
in superficial inguinal lymphnodes. The frequency of this
phenomenon is estimated at 2-10% [6]. This situation is
caused either by the existence of non-typical lymphatic
drainage omitting the superficial inguinal lymphnodes,
or by the presence of micrometastases within superficial
nodes overlooked during routine pathological exami-
nation [6].
In order to achieve a unified surgical approach for
patients with metastases within superficial inguinal
lymphnodes, multicentered randomized trials are
necessary.
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